Skip to main content

3M Plaintiffs Undergo Medical Exams And Hearing Tests

3M Plaintiffs Undergo Medical Exams And Hearing Tests

3M Plaintiffs Undergo Medical Exams And Hearing Tests

Introduction

Medical examinations and hearing tests of the plaintiffs involved in the 3M earplugs lawsuits started last week as per the protocol set by U.S. District Judge Casey Rodgers, overseeing the litigation in the Northern District of Florida.

The case order drawing the protocol of the examinations was released earlier this month for the first set of military veterans who are a part of initial bellwether trials.

According to the order, the total examination time for each plaintiff was set to four hours, and the results of the test had to be produced to the plaintiffs within seven days following the examination. The parties also have the opportunity to conduct rebuttal tests.

The first series of individual bellwether trials are scheduled to begin on April 5, 2021, during which the results of the testing will be used.

The result of these trials will not hold an obligation on other cases and will be closely monitored by the parties as it would influence settlements for veterans, which would avoid the need for individual trials nationwide in the coming years.

Currently, more than 150,000 claims are filed by veterans against 3M Company and its subsidiary Aearo Technologies, each raising similar allegations that the hearing loss injuries were caused by defective 3M earplugs that were standard issue by the military between 2003 and 2015.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!